Master patient flow analysis to predict pharma demand and provide better patient access.
16th June 2022Key considerations for creating more accurate patient-based product forecasts.
Expert strategies to overcome the inherent inaccuracy of long range pharma forecasting
27th May 2022Here we discuss why managing risk & opportunity is more important than accuracy when tackling your long range planning (LRP)
How J+D delivered a long-term forecasting model sooner than ever before using proprietary software tool
7th April 2022J+D were approached by a global pharmaceutical company with a broad pipeline across rare diseases, who needed an improved forecasting approach to evaluate a new extension line in greater detail and gain valuable insight from affiliates.
Big pharma boosts efficiency and gains a consistent forecasting approach with J+D’s FC365 platform
14th January 2022J+D were approached by a global pharmaceutical company who needed a new forecasting solution with a robust process management system to give them a solid foundation when forecasting their pipeline assets.
J+D helps pioneering biotech launch an efficient, best-practice forecasting process
21st October 2021A clinical-stage biotech, with a broad oncology pipeline required an improved forecasting approach to support their launch strategy and pipeline prioritisation decision-making for a novel and innovative oncology technology.
How Microsoft Teams streamlined cross-country forecasting for biotech pioneers.
23rd April 2021The background. In this case study, we showcase our latest work with one of Europe’s largest, leading biotechnology pioneers, helping to facilitate better, more collaborative forecasting for hundreds of colleagues across the continent. For the company’s most recent forecasting cycle, our experts have worked to…
J+D Forecasting strike the balance between simplicity and complexity when modelling for the liquid tumour market
12th August 2020The Challenge Identify a clear, transparent, and logical way to structure a forecast model to identify the potential for a new therapy in leukaemia. The model would be complex because patients go through different stages of treatment within a single line of treatment (for example,…
J+D Forecasting Changed the Forecasting Approach of a Global Biotech Forever
23rd July 2020One of the world’s first global biotechnology companies a leader, in innovative scientific research in neurological diseases approached J+D Forecasting with a set of forecasting challenges.